The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness, as well as changing how the body processess food. (In other countries, tirzepatide is also ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer in shortage after nearly two years. Pharmacies that sold unbranded ...